Datadog heads into its August 6 earnings report with one of the more interesting disconnects in software this week: a flood of bullish analyst revisions hitting the tape while the stock itself falls 6% on the week to $254.79.
The analyst activity has been unusually concentrated and one-directional. Ten firms raised price targets in the past three trading days — a cluster that is hard to ignore. TD Cowen and Guggenheim both moved to $300 on Wednesday, with Guggenheim's move the most aggressive, lifting its target from $225. Barclays raised to $290 and Wells Fargo to $295 on Monday, while UBS and Keybanc had already pushed targets to $315 and $320 respectively earlier in the week. The lone dissenter in the group was Jefferies, which raised its target to $280 but simultaneously downgraded the stock to Hold from Buy — a notable split that captures the core tension neatly. Nearly every firm on the Street sees upside from current levels; the mean target of $265 sits just above the current price. But Jefferies is signaling that the easy money has been made. The bull case rests on Datadog's AIOps leadership, a pipeline of 400-plus product features, and a structural advantage in data access that should compound through the AI infrastructure buildout. The bear case is blunter: the stock trades near 20x EV/revenue with a P/E above 95, and AI-driven cost pressures could eventually commoditize the very monitoring layer Datadog dominates.
Lending market conditions do nothing to complicate this picture — if anything, they confirm that bearish conviction is thin. Availability is extraordinarily loose, running near 9,765% of short interest, meaning roughly 327 million shares remain available to borrow against a total short position of just 14 million. That availability reading has roughly doubled over the past month as shorts have quietly unwound. Short interest at 4.3% of free float is modest and falling — down nearly 4% on the week and 6% over the past month. Cost to borrow, at 0.33%, is among the lowest levels of the past six weeks and has dropped 31% over 30 days. There is no short-side pressure building here. The ORTEX short score of 35.6 reflects that: it peaked near 36.5 on July 10 and has since drifted lower as positions were covered.
Options traders have moved slightly more defensive than usual, but only marginally so. The put/call ratio of 0.796 is running about two standard deviations above its 20-day average of 0.756 — the highest in roughly a month — suggesting some hedging activity ahead of the August 6 print. It is a mild signal rather than an alarming one, and nowhere near the 52-week high of 1.01. The more relevant data point is what happened after the last earnings release: the May 7 print produced a single-day gain of 39% and a five-day move of 41%, making it one of the largest post-earnings reactions in the software space this year. That result set a high bar for August, and the stock is already up 14% over the past month as the market has partially priced in continued execution.
On the institutional side, the notable item is modest selling by co-founders Olivier Pomel and Alexis Le-Quoc, who together trimmed roughly 568,000 shares in early July — routine for executives at this valuation level, and their combined stake remains above 4.9% of shares outstanding. BlackRock added 6.9 million shares through June, making it the largest institutional holder at 9.9% of the company. T. Rowe Price added 1.6 million shares over the same period. The institutional base is broadly supportive and growing, which sits in contrast to the insider trimming and provides the clearest picture of where long-term conviction actually lives.
The August 6 print is therefore less about whether Datadog is growing and more about whether growth is accelerating at a pace that justifies the post-May multiple expansion — with the Jefferies downgrade framing the question the Street will be asking all the way into the release.
See the live data behind this article on ORTEX.
Open DDOG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
